Business Insights, PHARMACY MARKET

Global Use of Medicines 2023

January 18, 2023

Global Use
Reaching a post-pandemic era is an alluring prospect for almost everyone around the world after the disruptions of the past three years. 

Spotlight

Boiron France / Boiron France

Boiron is a family-owned and independent pharmaceutical company. We are specialized in the manufacture of homeopathic medicines of very high quality for a century. Present in more than 50 countries, with 3,708 employees, we develop with rigor and passion our project for health. Boiron is an independent, family-run pharmaceutical laboratory.

OTHER WHITEPAPERS
news image

Pharma R&D Annual Review 2022 Navigating the Landscape

whitePaper | May 7, 2022

Citeline, Welcome to Pharmaprojects' 2022 reviews of trends in pharmaceutical R&D. Take a look at the evolution of pharma R&D and in this article, examine the state of play at the start of 2022.

Read More
news image

Overcoming technical challenges in cell-based high throughput screens

whitePaper | November 11, 2022

Tremendous technological advancements in automated biotechnology and combinatorial chemistry have led to the widespread implementation of high throughput screening (HTS) for drug discovery since the early 1990s.

Read More
news image

Combatting Future Viral Threats with Vaccine Advances

whitePaper | February 3, 2023

Since the beginning of the COVID-19 pandemic, pharmaceutical organizations have experienced major changes, a prime example of which has been the rising requirement for collaborations on multiple different fronts across the industry.

Read More
news image

High Pressure Homogenizer for Nano-formulation

whitePaper | December 16, 2022

NanoGenizer, a lab-scale microfluidic high pressure homogenizer, utilizes interaction high-pressure microfluidic jet technology, and it is equipped with highly modular power and processing units.

Read More
news image

Potential measures to facilitate the productions of activepharmaceutical ingredients (APIs)

whitePaper | March 27, 2023

European countries have been experiencing medicine shortages due to disruptions in the supply chain. Reshoring the productions of active pharmaceutical ingredients (APIs) is considered as an approach to secure the supply.

Read More
news image

Investing in Next-Generation Tokenization and Real-World Data to Unlock a More Precise and Complete Patient Journey

whitePaper | November 18, 2022

To realize the full potential of RWD, we must put the patient at the center and truly understand each patient’s unique circumstances over time. It’s certainly a tall order when the data we need is scattered across siloed systems and guarded by applicable and necessary patient privacy regulations.

Read More

Spotlight

Boiron France / Boiron France

Boiron is a family-owned and independent pharmaceutical company. We are specialized in the manufacture of homeopathic medicines of very high quality for a century. Present in more than 50 countries, with 3,708 employees, we develop with rigor and passion our project for health. Boiron is an independent, family-run pharmaceutical laboratory.

Events